Search

Paper: Suggestion for a new bacteriophage genus for the Klebsiella pneumoniae phage vB_KpnS-Carvaje

Paper: Topical liquid formulation of bacteriophages for metered-dose spray delivery

We warmly invite you to attend you to attend our 12th annual Oxford bacteriophage conference – the longest running phage conferences series in Europe – which will be held on 05-06 September 2022. We are committed to holding this conference

iVoM Season 2, hosted by ISVM, VoM 2022 and Phage Directory concluded recently with its 7th event. The recordings of all the events are now posted on the members page! The events spanned all aspects of viruses of microbes, and each featur

We warmly invite you to attend you to attend our 12th annual Oxford bacteriophage conference – the longest running phage conferences series in Europe – which will be held on 05-06 September 2022. We are committed to holding this conference

Hi everyone, I have isolated a few phages - 2 are Jumbo phage. I have sequnced (350 kbp) these phages. I need help in sequence analysis and can collaboratively publish it. Email: avtar2020@gmail.com

I was wondering if there was an unpublished case of a phage therapy done which I could write a case report about. If so please contact me at nameerap26@gmail.com

Adaptive Phage Therapeutics announced that the first patient has been dosed in its DFO Adaptive Novel Care Evaluation (DANCE™) trial, a Phase 1/2 clinical study to evaluate the safety and efficacy of APT’s precision phage therapy in patient

Preprint: Gram-positive bacteria evade phage predation through endolysin-mediated L-form conversion. Read author Martin Loessner’s Twitter thread on this report!

Opinion: Diversity in the soil virosphere: to infinity and beyond? Read author Simon Roux’s Twitter thread on this report!

Paper: Phage-mimicking nanoagents for rapid depolymerase specificity screening against multidrug resistant bacteria.

News article: Rediscovering phages: ‘We finally have the tools to harness them’.

Armata Pharmaceuticals announces first patient dosed in phase 1b/2a 'diSArm' study of AP-SA02 in adults with bacteremia due to Staphylococcus aureus.

Paper: A truncated anti-CRISPR protein prevents spacer acquisition but not interference

Paper: Computational tools for the analysis of uncultivated phage genomes

Paper: The gut environment regulates bacterial gene expression which modulates susceptibility to bacteriophage infection

Paper: An anti-MRSA phage from raw fish rinse: stability evaluation and production optimization.

Register here to attend the upcoming ESGNTA online course on ‘personalised phage therapy: basic principles of monitoring and treatment’. The online course will run from 7 - 10 June, 2022 with a great line-up of experts in the field.

Intralytix has been granted FDA clearance for an investigational new drug application for phase 1/2a clinical trials for vancomycin resistant Enterococci (VRE)-targeting phage.

Paper: Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. Also read this press release about the paper!